Litcius/Paper detail

Tezepelumab: First Approval

Sheridan M. Hoy

2022Drugs107 citationsDOIOpen Access PDF

Topics & Concepts

MedicineThymic stromal lymphopoietinAsthmaOmalizumabEosinophilicMepolizumabCOPDImmunologyNasal polypsEosinophilic esophagitisDiseaseInternal medicineImmunoglobulin EEosinophilAntibodyPathologyAsthma and respiratory diseasesEosinophilic EsophagitisIL-33, ST2, and ILC Pathways
Tezepelumab: First Approval | Litcius